During this phase, typically occuring several years prior to arthritis onset, genetic and environmental risk factors interact, leading to a loss of self-tolerance and the development of autoantibodies, such as rheumatoid factors (RF) and anti-citrullinated protein antibodies (ACPA) (2, 3). This evidence concerns the gene PRTN3 and arthritic joint disease.